Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNIC.L Regulatory News (CNIC)

  • There is currently no data for CNIC

Director Dealing

7 Apr 2022 07:00

RNS Number : 5568H
CentralNic Group PLC
07 April 2022
 

7 April 2022

CentralNic Group plc

 

("CentralNic" or the "Company")

Director Dealing

 

CentralNic Group Plc (AIM: CNIC) announces that it has been notified that on 4th April 2022 Don Baladasan, Group Managing Director and a director of the Company, entered into a facility agreement with W management Services Ltd pursuant to which 2,000,000 ordinary shares in the Company have been pledged as collateral. Don remains the beneficial owner of the shares, subject to the pledge, and retains full voting rights attaching to the shares.

 

As a result, Don's beneficial interest in CentralNic ordinary shares remains unchanged at 2,733,606 representing approximately 0.95% of the Company's issued share capital.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Don Baladasan

2

Reason for the notification

a)

Position/status

Group Managing Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CentralNic Group plc

b)

LEI

213800M4IINBWMXEKV82

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.001

 

GB00BCCW4X83

b)

Nature of the transaction

Shares pledged by Don Baladasan as collateral for any amounts which may become due under a loan with W management Services Ltd

c)

Price(s) and volume(s)

Exercise of share option

 Price(s)

Volume(s)

N/A

2,000,000

 

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

4 April 2022

f)

Place of the transaction

Outside of a trading venue

 

 

 

For further information:

 

CentralNic Group Plc

Ben Crawford, Chief Executive Officer

Don Baladasan, Group Managing Director

Michael Riedl, Chief Financial Officer

 +44 (0) 203 388 0600

Zeus (NOMAD and Joint Broker)

Nick Cowles / Jamie Peel / James Edis (Investment Banking)

Dominic King (Corporate Broking)

 +44 (0) 161 831 1512

+44 (0) 203 829 5000

Berenberg (Joint Broker)

Mark Whitmore / Richard Andrews / Alix Mecklenburg-Solodkoff

+44 (0) 20 3207 7800

 

SEC Newgate (for Media)

Bob Huxford / Max Richardson / Isabelle Smurfit

 

 

+44 (0) 203 757 6880

centralnic@secnewgate.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHMZGGDZVGGZZZ
Date   Source Headline
25th Apr 20237:00 amRNSResult of AGM
24th Apr 20237:01 amRNSBoard Changes
24th Apr 20237:00 amRNSTrading Update
17th Apr 20237:00 amRNSDirectors' Dealings
17th Apr 20237:00 amRNSShare Awards and Exercise of Options
14th Apr 202311:01 amRNSDirectors' Dealings and Holdings in Company
11th Apr 20233:08 pmRNSDirectors' Dealings
5th Apr 20234:13 pmRNSDirectors' Dealings
3rd Apr 20237:00 amRNSDirectors' Dealings
30th Mar 20238:56 amRNSDirectors’ Dealings
27th Mar 20233:26 pmRNSDirectors’ Dealings
27th Mar 20237:00 amRNSAnnual Report, Notice of Q1 Update, AGM & Dividend
22nd Mar 20231:35 pmRNSDirectors’ Dealings
17th Mar 20234:00 pmRNSHolding(s) in Company
17th Mar 20237:00 amRNSDirectors’ Dealings
16th Mar 20237:00 amRNSHolding(s) in Company
14th Mar 20237:00 amRNSDirectors' Dealings
10th Mar 20237:15 amEQSCentralNic (CNIC): Clarifying the narrative
9th Mar 20237:00 amRNSDirectors’ Dealings
6th Mar 20237:00 amRNSDirectors' Dealings
2nd Mar 20237:00 amRNSCentralNic among FT's fastest growing in Europe
27th Feb 20237:00 amRNSUnaudited Preliminary Accounts for Full Year 2022
31st Jan 20237:00 amRNSPartnership Announcement
30th Jan 20237:00 amRNSTrading Update, Board Changes, Notice of Results
25th Jan 20238:08 amRNSDirectors' Dealings
23rd Jan 20237:00 amRNSDirector Dealings
20th Jan 20237:00 amRNSNotification of Major Holdings
20th Jan 20237:00 amRNSDirectors' Dealings
19th Jan 20237:00 amRNSTransaction in Own Shares
17th Jan 20237:00 amRNSDirectors' Dealings
17th Jan 20237:00 amRNSTransaction in Own Shares
16th Jan 20237:00 amRNSTransaction in Own Shares
13th Jan 20237:00 amRNSTransaction in Own Shares
12th Jan 20238:14 amRNSDirectors' Dealings
12th Jan 20237:00 amRNSTransaction in Own Shares
11th Jan 20237:00 amRNSTransaction in Own Shares
10th Jan 20237:00 amRNSTransaction in Own Shares
10th Jan 20237:00 amRNSHolding(s) in Company
9th Jan 20234:17 pmRNSDirectors' Dealings
9th Jan 20237:00 amRNSTransaction in Own Shares
6th Jan 20238:13 amRNSShare Awards and exercise of Options
6th Jan 20237:00 amRNSTransaction in Own Shares
5th Jan 20237:00 amRNSTransaction in Own Shares
4th Jan 20237:00 amRNSTransaction in Own Shares
3rd Jan 20237:00 amRNSDirectors' Dealings
3rd Jan 20237:00 amRNSTransaction in Own Shares
30th Dec 20227:00 amRNSShare Buyback Programme
21st Dec 20226:17 pmRNSDirectors' Dealings
19th Dec 20227:00 amRNSAcquisition Announcement
16th Dec 20225:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.